Table 4

Summary of adverse events with onset during the treatment period to week 54 (intention-to-treat population)

Patients, n (%)
Any adverse event87 (98)
Adverse events leading to permanent discontinuation17 (19)
Drug-related adverse events56 (63)
Serious adverse events34 (38)
 Drug-related serious adverse events15 (17)
 Serious infections16 (18)
 Colon cancer1 (1)
 Death0